SEK 0.4
(-0.98%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | -1.34 Million SEK | 16.25% |
2022 | -1.6 Million SEK | -52.24% |
2021 | -1.05 Million SEK | -27.77% |
2020 | -822.57 Thousand SEK | -15.32% |
2019 | -713.28 Thousand SEK | -30.55% |
2018 | -546.37 Thousand SEK | -2918.64% |
2017 | -18.1 Thousand SEK | -1810100.0% |
2016 | 1.00 SEK | 0.0% |
2015 | 1.00 SEK | 100.0% |
2014 | -123.75 Thousand SEK | 0.0% |
2013 | - SEK | 0.0% |
2012 | - SEK | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | -1.18 Million SEK | 11.42% |
2024 Q3 | -1.69 Million SEK | 100.0% |
2024 Q2 | -383 Thousand SEK | 67.73% |
2023 Q2 | -1.45 Million SEK | -8.93% |
2023 Q1 | -1.33 Million SEK | 16.69% |
2023 FY | -1.34 Million SEK | 16.25% |
2023 Q4 | -1.34 Million SEK | 29.32% |
2023 Q3 | -1.89 Million SEK | -30.58% |
2022 Q3 | -1.49 Million SEK | 17.34% |
2022 FY | -1.6 Million SEK | -52.24% |
2022 Q4 | -1.6 Million SEK | -7.31% |
2022 Q1 | -2.75 Million SEK | -162.32% |
2022 Q2 | -1.8 Million SEK | 34.59% |
2021 Q1 | -1.2 Million SEK | 0.0% |
2021 Q4 | -1.05 Million SEK | 29.13% |
2021 Q3 | -1.48 Million SEK | -86.84% |
2021 FY | -1.05 Million SEK | -27.77% |
2021 Q2 | -793.9 Thousand SEK | 33.87% |
2020 Q1 | - SEK | 0.0% |
2020 Q2 | - SEK | 0.0% |
2020 Q3 | - SEK | 0.0% |
2020 Q4 | - SEK | 0.0% |
2020 FY | -822.57 Thousand SEK | -15.32% |
2019 Q2 | - SEK | 0.0% |
2019 Q1 | - SEK | 0.0% |
2019 Q4 | - SEK | 0.0% |
2019 Q3 | - SEK | 0.0% |
2019 FY | -713.28 Thousand SEK | -30.55% |
2018 Q2 | - SEK | 0.0% |
2018 Q4 | - SEK | 0.0% |
2018 FY | -546.37 Thousand SEK | -2918.64% |
2018 Q3 | - SEK | 0.0% |
2018 Q1 | - SEK | 0.0% |
2017 Q1 | 1.00 SEK | 0.0% |
2017 FY | -18.1 Thousand SEK | -1810100.0% |
2017 Q2 | 2.00 SEK | 100.0% |
2017 Q4 | - SEK | 0.0% |
2017 Q3 | - SEK | -100.0% |
2016 Q1 | 1.00 SEK | 0.0% |
2016 FY | 1.00 SEK | 0.0% |
2016 Q3 | - SEK | -100.0% |
2016 Q2 | 1.00 SEK | 0.0% |
2016 Q4 | 1.00 SEK | 0.0% |
2015 Q1 | - SEK | 0.0% |
2015 FY | 1.00 SEK | 100.0% |
2015 Q4 | 1.00 SEK | 0.0% |
2014 FY | -123.75 Thousand SEK | 0.0% |
2014 Q4 | - SEK | 0.0% |
2013 FY | - SEK | 0.0% |
2012 FY | - SEK | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
AcuCort AB | -1.09 Million SEK | -21.929% |
AlzeCure Pharma AB (publ) | -2508.00 SEK | -53329.027% |
BioGaia AB (publ) | 181.2 Million SEK | 100.739% |
Enzymatica AB (publ) | 11.49 Million SEK | 111.653% |
Enorama Pharma AB (publ) | 4.29 Million SEK | 131.221% |
Gabather AB (publ) | -1772.00 SEK | -75520.767% |
Klaria Pharma Holding AB (publ.) | - SEK | Infinity% |
Moberg Pharma AB (publ) | 7.11 Million SEK | 118.833% |
Nanexa AB (publ) | 1.91 Million SEK | 170.12% |
Newbury Pharmaceuticals AB (publ) | 4.99 Million SEK | 126.827% |
ODI Pharma AB | - SEK | Infinity% |
Orexo AB (publ) | 42.4 Million SEK | 103.16% |
Probi AB (publ) | 116.7 Million SEK | 101.148% |
Swedencare AB (publ) | 398.1 Million SEK | 100.337% |
Swedish Orphan Biovitrum AB (publ) | 3.87 Billion SEK | 100.035% |
Vivesto AB | - SEK | Infinity% |